Since the onset of the COVID-19 pandemic, there have been concerns over the mental
health impact of COVID-19. This is a review of the utilization of antidepressants, anxiolytics …

Background: The social restrictions among coronavirus disease 2019 (COVID-19) pandemic
have posed a thoughtful risk to mental health and have implications in the use of drugs …

Background Although the COVID-19 pandemic and its implications have been associated
with mental health services utilization and medication consumption, there is no longitudinal …

Objective To study sociodemographic and clinical factors associated with the long-COVID-
19 syndrome among women living in Latin American countries using undirected and …

Background Depression and anxiety have increased in prevalence since the start of the
COVID-19 pandemic. Objective To evaluate the consumption of antidepressants and …

Background The COVID-19 pandemic has had a significant impact on mental health, with
evidence suggesting an enduring mental health crisis. Studies worldwide observed …

Psychotropic drugs and benzodiazepines are nowadays among the primary substances of
abuse. This results in a large and constant release into aquatic environments where they …

Background Child and adolescent antidepressant use increased post-pandemic, but it is
unknown if this disproportionally affected those who develop post-acute sequelae of …

The increasing prevalence of mental health disorders has been matched with growing
psychotropic drug consumption rates around the world. Assessing …

Introduction Mental health conditions, such as depression, anxiety, and psychological
distress in the adult population significantly increased during the COVID-19 pandemic …